401 related articles for article (PubMed ID: 33665742)
1. The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme.
Maksoud S
Mol Neurobiol; 2021 Jul; 58(7):3252-3269. PubMed ID: 33665742
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities.
Zaky W; Manton C; Miller CP; Khatua S; Gopalakrishnan V; Chandra J
Cancer Metastasis Rev; 2017 Dec; 36(4):617-633. PubMed ID: 29071526
[TBL] [Abstract][Full Text] [Related]
3. Targeting the ubiquitin+proteasome system in solid tumors.
Driscoll JJ; Woodle ES
Semin Hematol; 2012 Jul; 49(3):277-83. PubMed ID: 22726552
[TBL] [Abstract][Full Text] [Related]
4. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
Staszczak M
Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.
Aliabadi F; Sohrabi B; Mostafavi E; Pazoki-Toroudi H; Webster TJ
Open Biol; 2021 Apr; 11(4):200390. PubMed ID: 33906413
[TBL] [Abstract][Full Text] [Related]
6. Targeting the ubiquitin proteasome system in haematological malignancies.
Crawford LJ; Irvine AE
Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
[TBL] [Abstract][Full Text] [Related]
7. p27 degradation by an ellipticinium series of compound via ubiquitin-proteasome pathway.
Pamarthy D; Tan M; Wu M; Chen J; Yang D; Wang S; Zhang H; Sun Y
Cancer Biol Ther; 2007 Mar; 6(3):360-6. PubMed ID: 17312389
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
Park J; Cho J; Song EJ
Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
[TBL] [Abstract][Full Text] [Related]
9. The role of ubiquitin-proteasome system in glioma survival and growth.
Vlachostergios PJ; Voutsadakis IA; Papandreou CN
Growth Factors; 2013 Jun; 31(3):106-13. PubMed ID: 23688106
[TBL] [Abstract][Full Text] [Related]
10. The role of the ubiquitin-proteasome pathway in cancer development and treatment.
Ding F; Xiao H; Wang M; Xie X; Hu F
Front Biosci (Landmark Ed); 2014 Jun; 19(6):886-95. PubMed ID: 24896323
[TBL] [Abstract][Full Text] [Related]
11. The role of the ubiquitin proteasome system in lymphoma.
Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A
Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
[TBL] [Abstract][Full Text] [Related]
13. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP
Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the ubiquitin-proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors.
Sanati M; Afshari AR; Ahmadi SS; Moallem SA; Sahebkar A
Biofactors; 2023; 49(4):782-819. PubMed ID: 37162294
[TBL] [Abstract][Full Text] [Related]
15. Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.
Vriend J; Klonisch T
Cell Mol Neurobiol; 2023 May; 43(4):1425-1452. PubMed ID: 35896929
[TBL] [Abstract][Full Text] [Related]
16. Corilagin induces human glioblastoma U251 cell apoptosis by impeding activity of (immuno)proteasome.
Qin X; Liu J; Pan D; Ma W; Cheng P; Jin F
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649855
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination and deubiquitination: Implications on cancer therapy.
Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
[TBL] [Abstract][Full Text] [Related]
18. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.
Narayanan S; Cai CY; Assaraf YG; Guo HQ; Cui Q; Wei L; Huang JJ; Ashby CR; Chen ZS
Drug Resist Updat; 2020 Jan; 48():100663. PubMed ID: 31785545
[TBL] [Abstract][Full Text] [Related]
19. The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
Yerlikaya A; Kanbur E; Stanley BA; Tümer E
Anticancer Agents Med Chem; 2021; 21(1):20-32. PubMed ID: 32781973
[TBL] [Abstract][Full Text] [Related]
20. Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.
Yang H; Chen X; Li K; Cheaito H; Yang Q; Wu G; Liu J; Dou QP
Semin Cancer Biol; 2021 Jan; 68():105-122. PubMed ID: 31883910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
